PDCI releases new issue of PDCI Market Access INSIGHTS, featuring research and opinion on the evolving state of private health insurance in Canada.
VOLUME 2, ISSUE 1
We share detail on our updated Census of Insurers, providing more depth and capacity for analysis on lives covered by private insurers and PBM’s. PDCI’s Paul Henricks offers insights about the possible impact on lives covered of pending relationship changes.
Mark Fleming summarizes a discussion panel with community pharmacists about private drug plans and how plan design has impacted their ability to care for patients. Readers will be particularly interested in the comments about patient programs and how pharmacists feel about both the business impacts and quality of care issues.
Our Q&A features Denise Balch offering an update on simplifying prior authorization. Since the release of her report a year ago, prior authorization is still a complex mix of technology, paper forms and prior authorization rules. But, as Denise reports, there are some positive signs for moving forward.
What is the PDCI Market Access Toolkit?
The PDCI Market Access Toolkit complements PDCI’s existing suite of Canadian focused pricing and reimbursement services with essential private health insurance insights and analytics. The Toolkit has been a critical resource to the pharmaceutical industry for more than 20 years.
A subscription to the PDCI Market Access Toolkit includes:
- PDCI Census of Insurers
- Annual review of private insured lives
- Historic Census data
- Breakdown of lives covered by insurer, province, and plan type
(Open, Managed (Private) and Government Mimic Formularies)
- PDCI INSIGHTS Journal including regular contributions from leaders in private access and Canadian private payer access highlights.
To learn more about PDCI’s Market Access Toolkit or learn more about our other pricing and reimbursement services, contact John Anacleto Director, Private Payer Strategies and Data Insights, at email@example.com.